Patents by Inventor Matthew Wightlin

Matthew Wightlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANALYTE SENSORS HAVING A SIGNAL-TO-NOISE RATIO SUBSTANTIALLY UNAFFECTED BY NON-CONSTANT NOISE
    Publication number: 20070235331
    Abstract: Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
    Type: Application
    Filed: May 18, 2007
    Publication date: October 11, 2007
    Applicant: DexCom, Inc.
    Inventors: Peter Simpson, Robert Boock, James Petisce, Mark Brister, Monica Rixman, Kum Ming Woo, Lisa Nguyen, Seth Brunner, Arthur Chee, Melissa Nicholas, Matthew Wightlin, Jack Pryor, Dubravka Markovic
  • Analyte sensor
    Publication number: 20060155180
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 22, 2006
    Publication date: July 13, 2006
    Inventors: Mark Brister, Steve Masterson, Sean Saint, Peter Simpson, Matthew Wightlin, James Petisce, Jack Pryor, Vance Swanson, John Nolting
  • Polymorphic and amorphous forms of 2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2 pyridin-2-YL-vinyl)-1H-indazol-6-ylamino]-phenyl}-amide
    Publication number: 20050267158
    Abstract: The invention provides several polymorphic forms and an amorphous form of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylamino]-phenyl}-amide, pharmaceutical compositions containing such polymorphic or amorphous forms, and methods of using such pharmaceutical compositions to treat disease states mediated by protein kinases, such as cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation.
    Type: Application
    Filed: March 15, 2005
    Publication date: December 1, 2005
    Inventors: Qiang Ye, Scott Zook, Michael Ouellette, Don Hettinger, Jayaram Srirangam, Robert Kania, Nabil Saeed, Matthew Wightlin, Mark Mitchell